Evidence map›Paper›PMID 36314791›Full record

ArticlemBio2022

Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons.

Weili Kong, Mauricio Montano, Michael J Corley, Ekram Helmy, Hirofumi Kobayashi, Martin Kinisu, Rahul Suryawanshi, Xiaoyu Luo, Loic A Royer, Nadia R Roan and 3 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 3 pooled it
14.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 3 syntheses or guidelines pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. A survey of SARS-CoV-2 tropism.Infectious diseases & immunity · 2025
    Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Weili KongMichael Hulton Center for HIV Cure Research at Gladstone, San Francisco, California, USA.
Mauricio MontanoMichael Hulton Center for HIV Cure Research at Gladstone, San Francisco, California, USA.
Michael J CorleyDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicinegrid.471410.7, New York, New York, USA.
Ekram HelmyMichael Hulton Center for HIV Cure Research at Gladstone, San Francisco, California, USA.
Hirofumi KobayashiCZ Biohub, San Francisco, California, USA.
Martin KinisuMichael Hulton Center for HIV Cure Research at Gladstone, San Francisco, California, USA.
Rahul SuryawanshiGladstone Institute of Virology, San Francisco, California, USA.
Xiaoyu LuoMichael Hulton Center for HIV Cure Research at Gladstone, San Francisco, California, USA.
Loic A RoyerCZ Biohub, San Francisco, California, USA.
Nadia R RoanMichael Hulton Center for HIV Cure Research at Gladstone, San Francisco, California, USA.
Melanie OttMichael Hulton Center for HIV Cure Research at Gladstone, San Francisco, California, USA.
Lishomwa C NdhlovuDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicinegrid.471410.7, New York, New York, USA.
Warner C GreeneMichael Hulton Center for HIV Cure Research at Gladstone, San Francisco, California, USA.ORCID 0000-0001-9896-8615
Gladstone Institutes · USChan Zuckerberg Biohub San Francisco · USCornell University · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 1988 to 2026
$93.6M
Exploring HIV-associated Neurocognitive Disorder (HAND) and HIV Latency at the Single Cell Level in Cerebral OrganoidsR01DA049525 · NIDA · J. DAVID GLADSTONE INSTITUTES · PI OTT, MELANIE MARIA · 2019 to 2023
$3.5M
NIAID NIH HHS P30 AI027763NIDA NIH HHS R01 DA049525
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is frequently associated with neurological deficits, but how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces these effects remains unclear. Here, we show that astrocytes are readily infected by SARS-CoV-2, but surprisingly, neuropilin-1, not angiotensin-converting enzyme 2 (ACE2), serves as the principal receptor mediating cell entry. Infection is further positively modulated by the two-pore segment channel 2 (TPC2) protein that regulates membrane trafficking and endocytosis. Astrocyte infection produces a pathological response closely resembling reactive astrogliosis characterized by elevated type I interferon (IFN) production, increased inflammation, and the decreased expression of transporters of water, ions, choline, and neurotransmitters. These combined events initiated within astrocytes produce a hostile microenvironment that promotes the dysfunction and death of uninfected bystander neurons.

Indexed as

COVID-19AstrocytesBrainHumansInflammationNeuronsNeuropilin-1OrganoidsSARS-CoV-2Neuropilin-1astrocytesCOVID-19human iPSC-derived brain organoidsinflammationinnate immunityneuronal dysfunction

Identifiers

PMID36314791
PMCPMC9765283
OpenAlexW4307777128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.